Burns Life Sciences Consulting GmbH
For Tyler's personal website, go here.
Book a free 30-minute call.
Table of Contents
AI-Bio Research, Strategy, Product Development, and Scientific Communication
We help biotech, bioinformatics, AI, and biosecurity organizations understand, evaluate, build, and communicate work at the frontier of AI and biology.
Burns LSC works with teams facing ambiguous AI-Bio questions: what is real, what is useful, what is risky, what should be built next, and how should it be explained to the people who need to act on it?
The AI-Bio frontier
AI is making routine bioinformatics easier to automate. The more valuable questions now sit upstream:
- Which AI capabilities actually work in biological contexts?
- Which workflows can be automated, augmented, or turned into products?
- Which demos are real, and which are brittle or misleading?
- Where do frontier AI systems create new biological risks?
- What should an organization build, buy, evaluate, or avoid?
- How should complex AI-Bio work be communicated to users, funders, customers, or leadership?
These questions require biological judgment, computational depth, product sense, clear communication, and disciplined execution.
That is where we work.
What we do
We help organizations make better decisions and build useful systems at the intersection of AI and biology.
Our work combines:
- Computational biology
- Single-cell and spatial omics
- High-dimensional cytometry
- AI-assisted scientific workflows
- LLM and agent evaluation
- Bioinformatics product strategy
- AI-biosecurity research
- Prototype and product development
- Science communication
- Project operations
The goal is not to “add AI.” The goal is to find where AI creates real leverage, where it is likely to fail, what should be built, and how the work should be translated into action.
Who we help
Bioinformatics and biotech companies
We help companies integrate AI into products, platforms, workflows, and strategy.
Common projects include:
- AI product strategy
- Roadmap review
- Workflow automation
- AI-native scientific user experiences
- Agentic analysis prototypes
- LLM evaluation on biological tasks
- Internal tools for analysis, support, or customer success
- Customer-facing scientific communication
Typical questions:
- How should we integrate AI into our product?
- Which parts of our workflow are now automatable?
- What should our AI roadmap look like?
- How do we avoid building a flashy demo that fails in real scientific use?
- How do we explain complex AI-Bio capabilities clearly to customers, investors, or internal teams?
AI-biosecurity organizations
We help nonprofits, funders, and research groups study the implications of frontier AI systems for biological risk.
Common projects include:
- Red-line research
- AI-bio threat modeling
- Dual-use workflow evaluation
- Capability assessment
- Defensive tooling
- Technical research support
- Research communication and reporting
Typical questions:
- What biological capabilities might frontier AI systems enable?
- Where are the practical red lines?
- How should risky workflows be evaluated?
- What tools would help analysts, researchers, or institutions respond effectively?
- How can technical research be turned into clear outputs for funders, policymakers, or partner organizations?
Leaders, investors, and funders navigating AI-Bio
We help founders, executives, technical leads, investors, and funders understand what is happening at the AI-Bio frontier and what to do next.
Common projects include:
- Strategic briefings
- Technical due diligence
- Build / buy / partner decisions
- Product feasibility assessment
- Independent review of AI-Bio claims
- Communication strategy for technical or scientific work
Typical questions:
- Which AI-Bio claims in our pipeline or portfolio are real?
- What is actually working at the AI-Bio frontier today?
- Should we build, buy, partner, or wait on this capability?
- How large is the opportunity, and what could go wrong?
- How do we explain this work clearly to our board, LPs, or stakeholders?
Ways to work together
AI-Bio strategy
A focused engagement to clarify where AI can create value, where it is likely to fail, and what your team should do next.
Typical outputs:
- Opportunity map
- Risk and feasibility assessment
- Product or research roadmap
- Recommended experiments
- Build / buy / partner recommendations
- Decision memo for leadership, investors, or funders
AI-Bio prototyping
A hands-on engagement to turn an idea into a working prototype, internal tool, evaluation, or demo.
Typical outputs:
- Working prototype
- Agentic workflow
- AI-assisted analysis system
- Evaluation harness
- Demo-ready product concept
- Technical writeup and next-step roadmap
AI-biosecurity research and product development
Technical research and product development for organizations studying biological risk from frontier AI systems.
Typical outputs:
- Red-line analysis
- Model capability assessment
- Trend identification and tracking
- Research and trend dashboards
- Technical report for internal or external audiences
Scientific communication and operations
Support for teams that need complex AI-Bio work turned into clear, organized, communication-ready outputs.
Typical outputs:
- Reports and white papers
- Website or product copy
- Grant, funder, or stakeholder materials
- Complex project planning, timelines, and execution
- Convening, conference, and event planning
- Technical-to-nontechnical translation
- Operational support for research or product projects
Fractional AI-Bio product or research support
Ongoing support for organizations that need senior judgment across AI, biology, product, communication, and execution without hiring a full-time team.
This can include product strategy, technical review, prototype supervision, partner evaluation, customer discovery, scientific workflow design, communication support, and project operations.
Why Burns LSC
Burns LSC is led by Tyler and Marie Burns.
Tyler brings deep expertise in computational biology, single-cell and spatial biology, cytometry, AI-assisted scientific workflows, product development, and AI-biosecurity research.
Marie brings expertise in science communication and operations, helping turn complex technical work into clear narratives, usable deliverables, and well-run projects.
Together, we help organizations move from ambiguous AI-Bio questions to concrete decisions, prototypes, workflows, and communication-ready outputs.
What people are saying
“BLS Consulting has brought tremendous value to Alkahest’s research efforts. Their extensive expertise helped us advance cutting-edge projects both in the scientific foundation, as well as the technical implementation. They’re the rare organization that can distill the ambiguity of advanced research down to pragmatic solutions with demonstrable value.”
— Scott Lohr, Senior Director of Informatics & Engineering, Alkahest Inc.
"Tyler’s expertise in data science, deep biological knowledge, and mastery of cutting-edge technologies have been instrumental in advancing several of our projects. His innovative thinking, coupled with his organization and responsiveness, make him an invaluable consultant. Tyler is our go-to person whenever we encounter challenges, and I greatly appreciate his commitment to efficiency and passion for both the team and the science."
— Bahareh Ajami, Assistant Professor of Immunology, Oregon Health & Science University
“Tyler’s sharp data science expertise on top of his deep biological background and first principles mindset has given us quality solutions every time we’ve brought him in.”
— Xiaoyan Qian, Senior Computational Biologist, 10x Genomics
“Tyler’s innovative data analysis solutions transformed our raw data into actionable insights, enabling us to make smarter and more informed decisions going forward. His fast and engaged approach makes working with him very enjoyable and informative, and we look forward to engaging his services again in future projects.”
— Natalia Becares, Principal Scientist, LIfT Biosciences
"We greatly appreciated the highly professional collaboration on the analysis and interpretation of single-cell sequencing data to identify regulated genes as potential pharmacodynamic markers within specific cell populations. The team demonstrated strong scientific insight, excellent adaptability, and delivered high-quality results in a timely manner."
— Hilmar Ebersbach, CSO, ImmunOs Therapeutics
Contact us
Tyler and Marie maintain active LinkedIn presences. If you are not connected, send a connection request with a short message. If we cannot answer your question directly, we may be able to point you toward someone who can.
Back to topBook a free 30-minute consultation
If you would like our perspective on an AI-Bio question, or want to explore a potential engagement or partnership, you can book a call here.
Insights
A compendium of Tyler's social media posts
These are grouped by subject and are easier to browse here than through LinkedIn history.